Please reload

Recent Posts

Boustead Securities Client ADOMANI First to IPO on NASDAQ Under the Jobs Act Regulation A+. Shares Up 92%.

June 19, 2017

1/1
Please reload

Featured Posts

Boustead Securities visits client PetCure Oncology's Lakeshore (WI) Clinic

August 1, 2019

 

Boustead Securities visits PetCure Oncology's Lakeshore (WI) Clinic to meet key team members using the Varian linear accelerator to treat tumors in pets via stereotactic radiation therapy (SRT).

 

Pictured above: Boustead's Brinson Lingenfelter and CEO Keith Moore with PetCure Oncology's Jenny Elliot, Radiation Therapist, Deb Fitzpatrick, Practice Director and Meredith Spence, Client Care Liaison of the Lakeshore (WI) Clinic.

 

PetCure Oncology's Jenny Elliot describes the protocols for using the Varian linear accelerator on pets to Boustead's Brinson Lingenfelter

 

PetCure Oncology's Varian linear accelerator to treat tumors in pets via stereotactic radiation therapy (SRT).

 

Learn more about PetCure Oncology here.

Share on Facebook
Share on Twitter
Please reload

Follow Us